HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

South Korea · Delayed Price · Currency is KRW

4,325.00

-80.00 (-1.82%)

At close: Oct 23, 2026

Market Cap	129.75B -4.3%
Revenue (ttm)	140.70B +11.5%
Net Income	13.35B
EPS	444.37
Shares Out	30.00M
PE Ratio	9.73
Forward PE	n/a
Dividend	70.00 (1.62%)
Ex-Dividend Date	Apr 2, 2026

Volume	158,760
Open	4,300.00
Previous Close	4,405.00
Day's Range	4,265.00 - 4,375.00
52-Week Range	3,125.00 - 6,240.00
Beta	0.77
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About HYUNDAI BIOLAND

HYUNDAI BIOLAND Co.,Ltd., together with its subsidiaries, manufactures and sells cosmetic raw materials, health food raw materials, medical devices, and pharmaceutical raw materials worldwide. The company offers cosmetics, such as whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products, as well as general/health functional food ingredients. It is also involved in the provision of medical biomaterials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supplying of active pha... [Read more]

Industry Pharmaceutical Preparations

Founded 1995

Employees 338

Stock Exchange KOSDAQ

Ticker Symbol 052260

Full Company Profile

Financial Performance

In 2025, HYUNDAI BIOLAND's revenue was 130.51 billion, an increase of 9.19% compared to the previous year's 119.52 billion. Earnings were 252.62 million, a decrease of -95.57%.

Financial Statements